Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

New melanocortin-like peptide of E. coli can suppress inflammation via the mammalian melanocortin-1 receptor (MC1R): possible endocrine-like function for microbes of the gut.

Qiang X, Liotta AS, Shiloach J, Gutierrez JC, Wang H, Ochani M, Ochani K, Yang H, Rabin A, LeRoith D, Lesniak MA, Böhm M, Maaser C, Kannengiesser K, Donowitz M, Rabizadeh S, Czura CJ, Tracey KJ, Westlake M, Zarfeshani A, Mehdi SF, Danoff A, Ge X, Sanyal S, Schwartz GJ, Roth J.

NPJ Biofilms Microbiomes. 2017 Nov 13;3:31. doi: 10.1038/s41522-017-0039-9. eCollection 2017.

2.

"Merinoff symposium 2010: sepsis"-speaking with one voice.

Czura CJ.

Mol Med. 2011 Jan-Feb;17(1-2):2-3. doi: 10.2119/molmed.2010.00001.commentary. No abstract available.

3.

Sepsis poses life-threatening response to infection.

Czura CJ, Distlerath L.

MLO Med Lab Obs. 2010 Nov;42(11):14. No abstract available.

PMID:
21128531
4.

Merinoff symposium 2010: sepsis--an international call to action.

Czura CJ.

Mol Med. 2010 May-Jun;16(5-6):157-8. doi: 10.2119/molmed.2010.00001.editorial. No abstract available.

5.

Vagus nerve stimulation regulates hemostasis in swine.

Czura CJ, Schultz A, Kaipel M, Khadem A, Huston JM, Pavlov VA, Redl H, Tracey KJ.

Shock. 2010 Jun;33(6):608-13. doi: 10.1097/SHK.0b013e3181cc0183.

6.

Experimental therapeutic strategies for severe sepsis: mediators and mechanisms.

Parrish WR, Gallowitsch-Puerta M, Czura CJ, Tracey KJ.

Ann N Y Acad Sci. 2008 Nov;1144:210-36. doi: 10.1196/annals.1418.011. Review.

PMID:
19076379
7.

Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.

Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang LH, Hudson L, Lin X, Patel N, Johnson SM, Chavan S, Goldstein RS, Czura CJ, Miller EJ, Al-Abed Y, Tracey KJ, Pavlov VA.

Mol Med. 2008 Sep-Oct;14(9-10):567-74. doi: 10.2119/2008-00079.Parrish.

8.

Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.

Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ.

Crit Care Med. 2007 Dec;35(12):2762-8.

PMID:
17901837
9.

Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis.

Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE, Tracey KJ.

Mol Med. 2007 Mar-Apr;13(3-4):210-5.

10.

CD38 and CD157: biological observations to clinical therapeutic targets.

Czura AW, Czura CJ.

Mol Med. 2006 Nov-Dec;12(11-12):309-11.

11.

Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.

Pavlov VA, Ochani M, Yang LH, Gallowitsch-Puerta M, Ochani K, Lin X, Levi J, Parrish WR, Rosas-Ballina M, Czura CJ, Larosa GJ, Miller EJ, Tracey KJ, Al-Abed Y.

Crit Care Med. 2007 Apr;35(4):1139-44.

PMID:
17334244
12.

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H.

Shock. 2006 Aug;26(2):174-9.

PMID:
16878026
13.

Role of HMGB1 in apoptosis-mediated sepsis lethality.

Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, Lin X, Sherry B, Kumar A, Larosa G, Newman W, Tracey KJ, Yang H.

J Exp Med. 2006 Jul 10;203(7):1637-42. Epub 2006 Jul 3.

14.

Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis.

Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L.

J Exp Med. 2006 Jul 10;203(7):1623-8. Epub 2006 Jun 19.

15.

Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia.

Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ.

Shock. 2006 Jun;25(6):571-4.

PMID:
16721263
16.

Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia.

Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ, Al-Abed Y, Tracey KJ.

Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5219-23. Epub 2006 Mar 20.

17.

The cytokine activity of HMGB1.

Yang H, Wang H, Czura CJ, Tracey KJ.

J Leukoc Biol. 2005 Jul;78(1):1-8. Epub 2005 Feb 25. Review.

PMID:
15734795
18.

Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.

Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K, Ulloa L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H.

J Lipid Res. 2005 Apr;46(4):623-7. Epub 2005 Feb 1.

19.

Autonomic neural regulation of immunity.

Czura CJ, Tracey KJ.

J Intern Med. 2005 Feb;257(2):156-66.

20.

Pathogenic role of HMGB1 in SARS?

Chen G, Chen DZ, Li J, Czura CJ, Tracey KJ, Sama AE, Wang H.

Med Hypotheses. 2004;63(4):691-5.

PMID:
15325019
21.

Recombinant HMGB1 with cytokine-stimulating activity.

Li J, Wang H, Mason JM, Levine J, Yu M, Ulloa L, Czura CJ, Tracey KJ, Yang H.

J Immunol Methods. 2004 Jun;289(1-2):211-23.

PMID:
15251426
22.

HMGB1 in the immunology of sepsis (not septic shock) and arthritis.

Czura CJ, Yang H, Amella CA, Tracey KJ.

Adv Immunol. 2004;84:181-200. Review. No abstract available.

PMID:
15246253
23.

Lipid unites disparate syndromes of sepsis.

Wang H, Czura CJ, Tracey KJ.

Nat Med. 2004 Feb;10(2):124-5. No abstract available.

PMID:
14760415
24.

Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway.

Czura CJ, Friedman SG, Tracey KJ.

J Endotoxin Res. 2003;9(6):409-13. Review.

PMID:
14733730
25.

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):296-301. Epub 2003 Dec 26.

26.

The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ.

Mol Med. 2003 May-Aug;9(5-8):125-34. Review.

27.

High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.

Czura CJ, Yang H, Tracey KJ.

J Infect Dis. 2003 Jun 15;187 Suppl 2:S391-6.

PMID:
12792856
28.

Structural basis for the proinflammatory cytokine activity of high mobility group box 1.

Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, Wang H, Warren HS, Moldawer LL, Fink MP, Andersson U, Tracey KJ, Yang H.

Mol Med. 2003 Jan-Feb;9(1-2):37-45.

29.

HMGB1 as a cytokine and therapeutic target.

Yang H, Wang H, Czura CJ, Tracey KJ.

J Endotoxin Res. 2002;8(6):469-72. Review.

PMID:
12697092
30.

The gesture life of high mobility group box 1.

Friedman SG, Czura CJ, Tracey KJ.

Curr Opin Clin Nutr Metab Care. 2003 May;6(3):283-7. Review.

PMID:
12690260
31.

Targeting high mobility group box 1 as a late-acting mediator of inflammation.

Czura CJ, Tracey KJ.

Crit Care Med. 2003 Jan;31(1 Suppl):S46-50. Review.

PMID:
12544976
32.

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ.

Nature. 2003 Jan 23;421(6921):384-8. Epub 2002 Dec 22.

PMID:
12508119
33.

Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion.

Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, Tracey KJ.

J Vasc Surg. 2002 Dec;36(6):1231-6.

34.

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.

Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ.

Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12351-6. Epub 2002 Sep 3.

35.

Pharmacological stimulation of the cholinergic antiinflammatory pathway.

Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ.

J Exp Med. 2002 Mar 18;195(6):781-8.

36.

HMGB1 as a late mediator of lethal systemic inflammation.

Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ.

Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1768-73. Review. No abstract available.

PMID:
11734424
37.

Dual roles for HMGB1: DNA binding and cytokine.

Czura CJ, Wang H, Tracey KJ.

J Endotoxin Res. 2001;7(4):315-21. Review.

PMID:
11717586
38.

Mind over immunity.

Tracey KJ, Czura CJ, Ivanova S.

FASEB J. 2001 Jul;15(9):1575-6. Review.

PMID:
11427490
39.

Balloon blunt-tip trocar for laparoscopic cholecystectomy: improvement over the traditional Hasson and Veress needle methods.

Bernik TR, Trocciola SM, Mayer DA, Patane J, Czura CJ, Wallack MK.

J Laparoendosc Adv Surg Tech A. 2001 Apr;11(2):73-8.

PMID:
11327130

Supplemental Content

Loading ...
Support Center